| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 03/04/2014 | US8664360 BSL3 polypeptides |
| 02/27/2014 | WO2014030624A1 Therapeutic agent for myotonic dystrophy, which contains stilbene derivative as active ingredient |
| 02/27/2014 | WO2014030514A1 Muscle atrophy inhibitor |
| 02/27/2014 | WO2014007620A3 Oligonucleotide for the treatment of muscular dystrophy patients |
| 02/26/2014 | EP2699269A1 New compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type 1 (dm1) |
| 02/26/2014 | EP2699249A1 Cartilage product |
| 02/26/2014 | CN103599438A Traditional Chinese medicine tincture for treating bone diseases and preparation method thereof |
| 02/26/2014 | CN103599416A Pharmaceutical composition for treating chronic lumbar strain |
| 02/26/2014 | CN103599316A Traditional Chinese medicinal composition for treating lumbar muscle pain on both sides and preparation method thereof |
| 02/26/2014 | CN103599202A Meridian application therapy drug |
| 02/26/2014 | CN103598778A Traditional Chinese medicine health-care cervical vertebra pillow |
| 02/26/2014 | CN102552107B Two-phase release preparation containing zolpidem or salt of zolpidem and preparation method thereof |
| 02/25/2014 | US8658623 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
| 02/20/2014 | WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions |
| 02/20/2014 | WO2014028025A1 Compositions and methods for treating myotonic dystrophy type 1 |
| 02/20/2014 | WO2014026372A1 Pharmaceutical composition for inhibiting autophagy of motor neurons and use thereof |
| 02/20/2014 | WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| 02/20/2014 | WO2013100566A8 Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
| 02/20/2014 | WO2009021750A3 Benzoxazole, benzimidazole and benzothiazole derivatives and their use in the treatment of duchenne muscular dytrophy |
| 02/20/2014 | US20140051753 Phenylcarbamate compound and muscle relaxant containing the same |
| 02/20/2014 | US20140051709 Compositions and Methods for Treating Myotonic Dystrophy Type 1 |
| 02/19/2014 | CN103589692A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 02/19/2014 | CN103588653A Polymorph of 4-methylbenzoate-4-[2-dimethylamino-1-(1-hydroxycyclohexyl) ethyl]phenyl-ester hydrochloride, and preparation method and application thereof |
| 02/19/2014 | CN103585468A Traditional Chinese medicine for treating graphospasm and preparation method thereof |
| 02/19/2014 | CN103585390A Traditional Chinese medicine composition for treating shoulder and arm pain and preparation method thereof |
| 02/19/2014 | CN103585389A Traditional Chinese medicine composition for treating limbs pain and preparation method thereof |
| 02/19/2014 | CN103585319A Traditional Chinese medicine composition for curing flaccid paralysis caused by liver-kidney deficiency and preparation method thereof |
| 02/19/2014 | CN103585135A Application of magnolol to preparation of medicine for treating cachexia and cancer |
| 02/18/2014 | US8653050 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
| 02/18/2014 | CA2331923C Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 02/13/2014 | WO2014026140A1 Methods for diagnosing, prognosing and treating muscular dystrophy |
| 02/13/2014 | WO2014024984A1 Hydrogen mixed gas supply device for medical purposes |
| 02/13/2014 | WO2014023007A1 Use of pedf-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis |
| 02/13/2014 | US20140045880 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 02/12/2014 | EP2695615A2 Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation |
| 02/12/2014 | EP2694653A2 Compounds and methods for altering activin receptor-like kinase signalling |
| 02/12/2014 | EP2694114A1 A skeletal muscle-specific enhancer |
| 02/12/2014 | EP2694061A2 Compounds for use as therapeutic agents affecting p53 expression and/or activity |
| 02/12/2014 | EP2694053A2 Selective androgen receptor modulators for treating diabetes |
| 02/12/2014 | CN103570806A 多肽环氧酮化合物 Peptide epoxy ketone compound |
| 02/12/2014 | CN103570730A Condensed ring pyridazinone compound with bridge ring structure as well as preparation method and application thereof |
| 02/12/2014 | CN103570715A Salt of uncaria alkaloid derivative |
| 02/12/2014 | CN103566201A Traditional Chinese medicine decoction for treating post-stroke hypermyotonia |
| 02/12/2014 | CN103566097A Traditional Chinese medicine composition for treating tetanus |
| 02/12/2014 | CN103565992A Scutellaria baicalensis-cortex phellodendri-coptidis rhizoma medicinal liquor and manufacture method thereof |
| 02/12/2014 | CN103565935A Traditional Chinese medicine composition for treating amyotrophy, osteocomma deformation and gout and preparation method thereof |
| 02/12/2014 | CN103565907A Persimmon calyx powder |
| 02/12/2014 | CN103565851A Empirical prescription for treating hiccup |
| 02/12/2014 | CN103565797A Medicine composition and application for inhibiting autophagy of motor neurons |
| 02/12/2014 | CN103565761A Galanthamine hydrobromide orally disintegrating tablet |
| 02/12/2014 | CN102617462B Specificity inhibition muscle micro ribonucleic acid compound and synthesis method and application thereof |
| 02/12/2014 | CN101955505B Immune suppressor and composition thereof |
| 02/11/2014 | US8648185 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 02/11/2014 | CA2560042C Hmb compositions and uses thereof |
| 02/11/2014 | CA2466632C Injectable depot compositions and uses thereof |
| 02/06/2014 | WO2014019855A1 Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof |
| 02/06/2014 | US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/06/2014 | US20140037616 Immunoglobulin 1 |
| 02/06/2014 | US20140037589 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 02/05/2014 | EP2692862A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases |
| 02/05/2014 | EP2692719A1 Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof |
| 02/05/2014 | CN103555678A A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2014 | CN103555677A A method of identifying unknown adeno-associated virus (avv) sequences and a kit for the metho |
| 02/05/2014 | CN103555676A A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2014 | CN103554222A Compounds for enzyme inhibition |
| 02/05/2014 | CN103554107A Azaadamantane derivatives and methods of use |
| 02/05/2014 | CN103554104A Azaindoles useful as inhibitors of jak and other protein kinases |
| 02/05/2014 | CN103550657A Galangal extract as well as preparation method and application thereof |
| 02/05/2014 | CN103550650A Preparation method of medicament for treating scapulohumeral periarthritis |
| 02/05/2014 | CN103550631A Medicine for treating sore muscle |
| 02/05/2014 | CN103550413A 膏药及其制备方法 Plaster and its preparation method |
| 02/05/2014 | CN103550196A Pharmaceutical formulations of amyloid inhibiting compounds |
| 02/05/2014 | CN103549074A Power lifting tea |
| 02/04/2014 | CA2727642C Synthesis of cyclosporin analogs |
| 01/30/2014 | WO2014016837A1 Compositions and methods for increasing carnitine level in muscle tissues |
| 01/30/2014 | WO2014016417A1 Hmgb1 variants and uses thereof |
| 01/30/2014 | WO2014015523A1 Novel heteroaryl and heterocycle compounds, compositions and methods |
| 01/30/2014 | US20140033335 Immunoglobulin 2 |
| 01/29/2014 | CN103539785A 大麻素受体调节剂 Cannabinoid receptor modulators |
| 01/29/2014 | CN103539769A Macrocyclic compounds useful as inhibitors of kinases and HSP90 |
| 01/29/2014 | CN103536857A Traditional Chinese medicine for treating flaccid paralysis |
| 01/29/2014 | CN103536822A Medicine for treating osteoproliferation and lumbar disc herniation |
| 01/29/2014 | CN103536599A Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 01/29/2014 | CN103536585A Method for preparing instant branched chain amino acid by extrusion method |
| 01/29/2014 | CN103536552A Cisatracurium besilate composition freeze-dried powder for injection |
| 01/29/2014 | CN101400406B Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 01/23/2014 | US20140024658 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 01/22/2014 | EP2687531A1 Tetrahydrocarboline derivative |
| 01/22/2014 | EP2686005A1 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |
| 01/22/2014 | EP2686004A1 Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |
| 01/22/2014 | EP2685987A2 Compositions and methods useful for ameliorating age related maladies |
| 01/22/2014 | EP2685973A1 Compositions and methods for the treatment of musculoskeletal related diseases and disorders using metal ion-citrate analog complexes |
| 01/22/2014 | EP2685841A1 Functional foods comprising diamine oxidase and uses thereof |
| 01/22/2014 | CN103524318A Application of allyl-containing monocarbonyl curcumin analogs in preparing antiinflammatory drugs |
| 01/22/2014 | CN103520569A Traditional Chinese medicine for treatment of lumbago of syndrome of yin deficiency of liver and kidney |
| 01/22/2014 | CN103520435A Agilawood health care essential oil |
| 01/22/2014 | CN103520366A Traditional Chinese medicine for treating spastic hemiplegia after stroke |
| 01/22/2014 | CN103520312A Traditional Chinese medicine for treating lumbar and leg pains |
| 01/22/2014 | CN103520296A Preparation method and application of purified coronary disease particle |
| 01/22/2014 | CN103520190A High-energy substance for preventing and treating neurodegenerative disease of old people and medical application of substance |